ProteinQure is a revenue-generating software platform for computational protein drug discovery. We combine molecular simulations, machine learning, and quantum computing to do the structure-based design of drugs. These physics-based methods make us less dependent on large data sets and that allows us to explore novel protein structures and interactions. We use our computational platform (as well as wet-lab validation) to solve our partner's drug design challenges and deliver new therapeutic candidates.
We have a very diverse team of multi-disciplinary scientists and engineers. We are based in Toronto, Canada, and are funded by top-tier venture firms. We focus on novel peptides optimized for binding, specificity, and other pharmacokinetic properties. In addition, we engineer proteins to incorporate multiple binding domains. Our platform allows our partners to leverage their proprietary wetlab technologies to interrogate biology in new ways.
Total Funding: $4.6 M
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2017
